跳至主要内容
临床试验/NCT04542018
NCT04542018已完成不适用

Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome

University of Michigan2 个研究点 分布在 1 个国家目标入组 48 人开始时间: 2020年8月3日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
48
试验地点
2
主要终点
Lactulose Mannitol Excretion

研究概览

简要总结

This research is studying whether changing an individual's diet may have an impact as a treatment or outcome for Irritable Bowel Syndrome (IBS). This research will show if diet might play a role in triggering changes that may cause IBS. This study is being done to learn if a low FODMAP (fermentable, oligosaccharides, disaccharides, monosaccharides, and polyols) diet causes changes in the colon lining which mediates improvement in IBS symptoms.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Normal serum studies including serum tissue-transglutaminase antibodies, thyroid stimulating hormone levels, C-reactive protein or fecal calprotectin, complete blood count since the onset of symptoms.
  • •Normal stool studies including, ova and parasites since the onset of symptoms
  • •IBS-SSS score of ≥175 at the end of the 7-day screening period
  • •In case of presence of any alarm features and/or elevated inflammatory markers (C-reactive protein or fecal calprotectin), patients will be eligible if they have been excluded for inflammatory bowel disease with colonoscopy in the last one year.

排除标准

  • •individuals already on a LFD or other dietary restriction such as gluten free diet within the past 6 months
  • •individuals with any known food allergy or insulin-dependent diabetes
  • •known history of celiac disease, inflammatory bowel disease or microscopic colitis
  • •prior small bowel or colonic surgery or cholecystectomy
  • •pregnant patients
  • •Antibiotics in the past 3 months
  • •Those who regularly use mast cell stabilizers or anti-histaminic or non-steroidal anti-inflammatory agents (NSAIDs) excluding daily baby aspirin or steroids or bile-acid binder.

研究组 & 干预措施

Study patients with IBS-D

Experimental

Patients with diarrhea-predominant IBS who will undergo a low FODMAP diet for 4 weeks

干预措施: a low FODMAP diet for 4 weeks (Other)

结局指标

主要结局

Lactulose Mannitol Excretion

时间窗: 4 weeks

Changes in cumulative excretion of lactulose and mannitol in timed urine collection before and after low FODMAP diet measured during 8-24h

次要结局

  • Changes in Epithelial Permeability - Quantitative Tight Junction Immunostaining(4 weeks)
  • Gastrointestinal Patient Reported Outcomes Measurement Information System (PROMIS)(4 weeks)
  • Changes in Stool Microbiome - Alpha Diversity(4 weeks)
  • Immunohistochemistry for Mast Cells(4 weeks)
  • Changes in Epithelial Permeability - Tight Junction Gene Expression(4 weeks)
  • Changes in Stool Microbiome - Beta Diversity(4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prashant Singh

Assistant Professor

University of Michigan

研究点 (2)

Loading locations...

相似试验